Cargando…

Risk score for non-small cell lung cancer patients starting checkpoint inhibitor treatment

BACKGROUND: Prognosis of metastatic non-small cell lung cancer significantly improved with the availability of checkpoint inhibitors (anti-PD-1/PD-L1). Unfortunately, reliable biomarkers to predict treatment benefit are lacking. PATIENTS AND METHODS: We prospectively collected clinical and laborator...

Descripción completa

Detalles Bibliográficos
Autores principales:	Diem, Stefan, Fässler, Mirjam, Hasan Ali, Omar, Siano, Marco, Niederer, Rebekka, Berner, Fiamma, Roux, Guillaume-Alexandre, Ackermann, Christoph Jakob, Schmid, Sabine, Güsewell, Sabine, Früh, Martin, Flatz, Lukas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6234997/ https://www.ncbi.nlm.nih.gov/pubmed/30519101 http://dx.doi.org/10.2147/CMAR.S179767

Ejemplares similares

Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patients
por: Fässler, Mirjam, et al.
Publicado: (2019)

Fingolimod and tumor-infiltrating lymphocytes in checkpoint-inhibitor treated cancer patients
por: Hasan Ali, Omar, et al.
Publicado: (2020)

Presence of autoantibodies in serum does not impact the occurrence of immune checkpoint inhibitor-induced hepatitis in a prospective cohort of cancer patients
por: Purde, Mette-Triin, et al.
Publicado: (2021)

C reactive protein flare predicts response to checkpoint inhibitor treatment in non-small cell lung cancer
por: Klümper, Niklas, et al.
Publicado: (2022)

Keratinocyte differentiation antigen-specific T cells in immune checkpoint inhibitor-treated NSCLC patients are associated with improved survival
por: Berner, Fiamma, et al.
Publicado: (2021)

Survival-Inferred Fragility Index of Phase 3 Clinical Trials Evaluating Immune Checkpoint Inhibitors
por: Bomze, David, et al.
Publicado: (2020)

Local tumor microbial signatures and response to checkpoint blockade in non-small cell lung cancer
por: Boesch, Maximilian, et al.
Publicado: (2021)

GLUT1-positive recurrent basal cell carcinoma of basosquamous subtype detected by positron emission tomography
por: Hasan Ali, Omar, et al.
Publicado: (2016)

Pembrolizumab-associated minimal change disease in a patient with malignant pleural mesothelioma
por: Bickel, Angelika, et al.
Publicado: (2016)

Association Between Immune-Related Adverse Events During Anti–PD-1 Therapy and Tumor Mutational Burden
por: Bomze, David, et al.
Publicado: (2019)

Biomarkers Associated with Immune-Related Adverse Events under Checkpoint Inhibitors in Metastatic Melanoma
por: Wölffer, Marcus, et al.
Publicado: (2022)

The role of radiation therapy in the management of small cell lung cancer
por: Glatzer, Markus, et al.
Publicado: (2017)

Sotorasib Shows Intracranial Activity in Patients with KRAS G12C-Mutated Adenocarcinoma of the Lung and Untreated Active Brain Metastases
por: Koster, Kira-Lee, et al.
Publicado: (2022)

Ejaculatory disorders after prostatic artery embolization: a reassessment of two prospective clinical trials
por: Müllhaupt, Gautier, et al.
Publicado: (2019)

Comparison of prostatic artery embolisation (PAE) versus transurethral resection of the prostate (TURP) for benign prostatic hyperplasia: randomised, open label, non-inferiority trial
por: Abt, Dominik, et al.
Publicado: (2018)

Aquablation versus holmium laser enucleation of the prostate in the treatment of benign prostatic hyperplasia in medium-to-large-sized prostates (ATHLETE): protocol of a prospective randomised trial
por: Müllhaupt, Gautier, et al.
Publicado: (2021)

In‐hospital cost analysis of prostatic artery embolization compared with transurethral resection of the prostate: post hoc analysis of a randomized controlled trial
por: Müllhaupt, Gautier, et al.
Publicado: (2019)

Emerging Therapies in Pheochromocytoma and Paraganglioma: Immune Checkpoint Inhibitors in the Starting Blocks
por: Fanciulli, Giuseppe, et al.
Publicado: (2020)

StartLink and StartLink+: Prediction of Gene Starts in Prokaryotic Genomes
por: Gemayel, Karl, et al.
Publicado: (2021)

Granuloma annulare arising under systemic psoriasis therapy successfully treated with adalimumab
por: Fässler, Mirjam, et al.
Publicado: (2020)

Heterologous Prime Boost Vaccination Induces Protective Melanoma-Specific CD8(+) T Cell Responses
por: Ring, Sandra S., et al.
Publicado: (2020)

Vaccination Strategies against Highly Pathogenic Arenaviruses: The Next Steps toward Clinical Trials
por: Ölschläger, Stephan, et al.
Publicado: (2013)

EML4-ALK-Positive Pulmonary Adenocarcinoma with an Unusual Metastatic Pattern: A Case Report
por: Diem, Stefan, et al.
Publicado: (2013)

Transcriptional pausing at the translation start site operates as a critical checkpoint for riboswitch regulation
por: Chauvier, Adrien, et al.
Publicado: (2017)

Predictors in starting and stopping Internet use between 2002 and 2012 by Dutch adults 65 years and older
por: Berner, Jessica, et al.
Publicado: (2017)

Cost-effectiveness of physical activity interventions in cancer survivors of developed countries: a systematic review
por: Gubler-Gut, Barbara E., et al.
Publicado: (2021)

Multiple measures derived from 3D photonic body scans improve predictions of fat and muscle mass in young Swiss men
por: Sager, Roman, et al.
Publicado: (2020)

In-depth Analysis of the 2019 Advanced Prostate Cancer Consensus Conference: The Importance of Representation of Medical Specialty and Geographic Regions
por: Pratsinis, Manolis, et al.
Publicado: (2021)

Density and sound velocity of saturated liquid neon-hydrogen and neon-deuterium mixtures between 25 nd 31 K
por: Güsewell, D, et al.
Publicado: (1970)

Chemical Starting Matter for HNF4α Ligand Discovery and Chemogenomics
por: Meijer, Isabelle, et al.
Publicado: (2020)

Pediatric hospital admissions, case severity, and length of hospital stay during the first 18 months of the COVID-19 pandemic in a tertiary children’s hospital in Switzerland
por: Bögli, Jasmin, et al.
Publicado: (2022)

Trajectories of fatigue in actively treated patients with established rheumatoid arthritis starting biologic DMARD therapy
por: Provan, Sella Aarrestad, et al.
Publicado: (2020)

A new chapter in immune checkpoint inhibitor therapy: starting with advanced lung squamous cell carcinoma
por: Fei, Kailun, et al.
Publicado: (2020)

Relapse of Birdshot Uveitis after Stopping Immunosuppressive Treatment and Starting Immune Checkpoint Inhibitors for Lung Cancer
por: Alsaddi, Mohammed A.M., et al.
Publicado: (2022)

Modern Aspects of Immunotherapy with Checkpoint Inhibitors in Melanoma
por: Petrova, Vera, et al.
Publicado: (2020)

Multicenter Phase II Study of Panitumumab in Platinum Pretreated, Advanced Head and Neck Squamous Cell Cancer
por: Siano, Marco, et al.
Publicado: (2017)

A Rare Case of Localized Argyria on the Face
por: Isak, Verena, et al.
Publicado: (2019)

Inflammatory markers in autoimmunity induced by checkpoint inhibitors
por: Husain, Beate, et al.
Publicado: (2021)

Structures of 9-1-1 DNA checkpoint clamp loading at gaps from start to finish and ramification to biology
por: Zheng, Fengwei, et al.
Publicado: (2023)

Structures of 9-1-1 DNA checkpoint clamp loading at gaps from start to finish and ramification on biology
por: Zheng, Fengwei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mgpkb6e05d3tfb13agk5krcda7